Rare Discovery: A Value in the Biotech World

Falling hepatitis C revenue has dented giants such as AbbVie and Gilead but created a rare bargain in biotech Enanta

from WSJ.com: Markets http://ift.tt/2mQKINm
via https://ifttt.com/ IFTTT